Technologies, Inc. is a privately held premier drug delivery
and specialty pharmaceuticals company. Founded in 1998, MicroDose
is pioneering the use of proprietary drug delivery platforms
for the pulmonary, oral and transdermal delivery of medications
for improved efficacy and compliance. MicroDose's current focus
is on the chronic disease states such as asthma, COPD, diabetes,
hypertension and hyperlipidemia.
improve the quality of life for people suffering from chronic
diseases by creating improved pharmaceutical products through
the application of proprietary drug delivery technologies.
MicroDose Technologies Announces Multi-Product Respiratory Collaboration for Its Next Generation Inhaler Device. MicroDose Technologies
Inc. (MicroDose) announced today that it has entered into a multi-product development and licensing agreement with Novartis
(NYSE: NVS) for the MicroDose proprietary dry powder inhaler (DPI)..
more news about MicroDose